Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.

Standard

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. / Kaaijk, P; Kaspers, G J L; Van Wering, E R; Broekema, G J; Loonen, A H; Hählen, K; Schmiegelow, K; Janka-Schaub, Gritta; Henze, G; Creutzig, U; Veerman, A J P.

in: BRIT J CANCER, Jahrgang 88, Nr. 5, 5, 2003, S. 775-781.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Kaaijk, P, Kaspers, GJL, Van Wering, ER, Broekema, GJ, Loonen, AH, Hählen, K, Schmiegelow, K, Janka-Schaub, G, Henze, G, Creutzig, U & Veerman, AJP 2003, 'Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.', BRIT J CANCER, Jg. 88, Nr. 5, 5, S. 775-781. <http://www.ncbi.nlm.nih.gov/pubmed/12618889?dopt=Citation>

APA

Kaaijk, P., Kaspers, G. J. L., Van Wering, E. R., Broekema, G. J., Loonen, A. H., Hählen, K., Schmiegelow, K., Janka-Schaub, G., Henze, G., Creutzig, U., & Veerman, A. J. P. (2003). Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. BRIT J CANCER, 88(5), 775-781. [5]. http://www.ncbi.nlm.nih.gov/pubmed/12618889?dopt=Citation

Vancouver

Kaaijk P, Kaspers GJL, Van Wering ER, Broekema GJ, Loonen AH, Hählen K et al. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. BRIT J CANCER. 2003;88(5):775-781. 5.

Bibtex

@article{657c40a9200d46e49839ed1ed8fc647f,
title = "Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.",
abstract = "Bone marrow and peripheral blood samples from 362 patients with acute lymphoblastic leukaemia (ALL) proliferating cell and 90 patients with acute myeloid leukaemia (AML) were analysed for S-phase fractions, Ki67 antigen, and proliferating cell nuclear antigen expression. The S-phase fractions were correlated with in vitro drug resistance to 15 different anticancer agents. Leukaemia cells isolated from bone marrow had higher S-phase fractions than leukaemia cells isolated from peripheral blood (in initial ALL, median values resp. 6.9 and 2.7%, in initial AML resp. 5.3 and 1.3%; both P",
author = "P Kaaijk and Kaspers, {G J L} and {Van Wering}, {E R} and Broekema, {G J} and Loonen, {A H} and K H{\"a}hlen and K Schmiegelow and Gritta Janka-Schaub and G Henze and U Creutzig and Veerman, {A J P}",
year = "2003",
language = "Deutsch",
volume = "88",
pages = "775--781",
journal = "BRIT J CANCER",
issn = "0007-0920",
publisher = "NATURE PUBLISHING GROUP",
number = "5",

}

RIS

TY - JOUR

T1 - Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.

AU - Kaaijk, P

AU - Kaspers, G J L

AU - Van Wering, E R

AU - Broekema, G J

AU - Loonen, A H

AU - Hählen, K

AU - Schmiegelow, K

AU - Janka-Schaub, Gritta

AU - Henze, G

AU - Creutzig, U

AU - Veerman, A J P

PY - 2003

Y1 - 2003

N2 - Bone marrow and peripheral blood samples from 362 patients with acute lymphoblastic leukaemia (ALL) proliferating cell and 90 patients with acute myeloid leukaemia (AML) were analysed for S-phase fractions, Ki67 antigen, and proliferating cell nuclear antigen expression. The S-phase fractions were correlated with in vitro drug resistance to 15 different anticancer agents. Leukaemia cells isolated from bone marrow had higher S-phase fractions than leukaemia cells isolated from peripheral blood (in initial ALL, median values resp. 6.9 and 2.7%, in initial AML resp. 5.3 and 1.3%; both P

AB - Bone marrow and peripheral blood samples from 362 patients with acute lymphoblastic leukaemia (ALL) proliferating cell and 90 patients with acute myeloid leukaemia (AML) were analysed for S-phase fractions, Ki67 antigen, and proliferating cell nuclear antigen expression. The S-phase fractions were correlated with in vitro drug resistance to 15 different anticancer agents. Leukaemia cells isolated from bone marrow had higher S-phase fractions than leukaemia cells isolated from peripheral blood (in initial ALL, median values resp. 6.9 and 2.7%, in initial AML resp. 5.3 and 1.3%; both P

M3 - SCORING: Zeitschriftenaufsatz

VL - 88

SP - 775

EP - 781

JO - BRIT J CANCER

JF - BRIT J CANCER

SN - 0007-0920

IS - 5

M1 - 5

ER -